Antitumor activity of a novel antisense oligonucleotide against Akt1. - Wikidata - wikimedia - TriplyDB

Antitumor activity of a novel antisense oligonucleotide against Akt1.

Antitumor activity of a novel antisense oligonucleotide against Akt1.

http://www.wikidata.org/entity/Q33941641

about

The notorious R.N.A. in the spotlight - drug or target for the treatment of disease Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape.Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.Akt inhibitors in clinical development for the treatment of cancer.Emerging therapies in pancreas cancer.Epidermal growth factor receptor as a therapeutic target in glioblastoma.Translational Approaches towards Cancer Gene Therapy: Hurdles and Hopes.Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma.Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer.Chromogranin A and its fragments as regulators of small intestinal neuroendocrine neoplasm proliferation.Enhanced sensitivity to sorafenib by inhibition of Akt1 expression in human renal cell carcinoma ACHN cells both in vitro and in vivo.

P2860

Q33739733-2F21F168-7E2E-4BBE-A323-83863712CAC5 Q33920097-6FA654D6-4D0D-4636-8DAD-F719B4359CC2 Q34307356-68363EFB-438A-43CD-98EA-6A389E5BFA21 Q35628576-B0DC41CE-C667-44EF-93AC-B5365BE6062B Q36097144-50D0C824-9511-41FD-AA4A-E53599EF5156 Q38098098-5F55EABC-0039-400D-8B81-A3340F7AD27E Q38107203-7DB49A98-8D62-43BD-B2A6-AC4669D2C7EB Q38111449-AD64BE9E-D73A-4B17-A8AA-6D1C3B8BD0EA Q38802193-991A1795-A3DA-4288-BD6C-60DAEE961E3F Q39059601-61550167-3D4B-4F81-B4E7-B0B0D69D22B7 Q55061628-6E0C3D77-606F-42B9-94B3-7468EC970960

P2860

Antitumor activity of a novel antisense oligonucleotide against Akt1.

http://www.wikidata.org/entity/Q33941641

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Antitumor activity of a novel antisense oligonucleotide against Akt1.

@ast

Antitumor activity of a novel antisense oligonucleotide against Akt1.

@en

type

label

Antitumor activity of a novel antisense oligonucleotide against Akt1.

@ast

Antitumor activity of a novel antisense oligonucleotide against Akt1.

@en

prefLabel

Antitumor activity of a novel antisense oligonucleotide against Akt1.

@ast

Antitumor activity of a novel antisense oligonucleotide against Akt1.

@en

P1433

Q33941641-4E55A4F6-DF58-4F54-AD87-1C33DCC958C3

P1476

Q33941641-78ABD570-242E-40EC-BAA3-1D4F26911E1A

P2093

Q33941641-15F9FBD3-7198-4F05-80E6-F42506306751

Q33941641-2F1D6206-72E2-44FE-BC72-FB109B0DA37A

Q33941641-304B50BE-4FFC-4375-9520-9BD1E3893999

Q33941641-A04717C2-5E0C-491C-8D73-ECE2685F9973

Q33941641-B29EF8DE-CA15-4350-91BA-D4BB1B84A77E

Q33941641-C93516C5-D31D-4779-B9AC-5AB761C09463

Q33941641-FD8D3D8C-DA45-49D3-94F7-659DA98E0DE9

P2860

Q33941641-04B25B45-8549-4038-B2EC-1434325F6EAD

Q33941641-056D043F-FEE4-41DD-B1AC-D8243367B9D1

Q33941641-067F5C29-37CE-42CF-B434-7FB783752679

Q33941641-0C36B18B-A243-4FE8-B3A8-803BEB9FC4D8

Q33941641-176ED562-A3E4-464B-BBD1-FCF1E63FB11A

Q33941641-18F92B80-8155-4328-82BC-7413B6A15EF5

Q33941641-36BDDE71-C9DD-48EC-9A77-F64BB493947A

Q33941641-3AAD0413-6AB2-4B50-883F-6B5219FF629E

Q33941641-3B76E544-2B41-468D-B430-2B0C75CDE30B

Q33941641-65715EC9-96DE-44F9-841D-A346CE2D6535

P304

Q33941641-20465ACE-B987-43BB-BBA0-C8C754878B8E

P31

Q33941641-888F5C25-DA45-4969-9543-4DD400BE891D

P356

Q33941641-1CFD723E-9076-46F0-941B-FB352142B3EE

P433

Q33941641-07F31378-54C4-4F49-8648-50683840D2EF

P478

Q33941641-A566B677-21C6-4BCD-9C4F-E75E23A81E76

P577

Q33941641-E7D74E7B-9EA4-43A4-A483-6D84574CA980

P5875

Q33941641-5C5AB480-0841-4FA8-9117-08491BFA4E62

P698

Q33941641-90847D4C-4CD9-400C-BFC7-BADCF45C4881

P932

Q33941641-FF5192F6-07DE-4E71-BB76-96F008CCDD8B

P356

P1433

Journal of Cellular Biochemistry

P1476

Antitumor activity of a novel antisense oligonucleotide against Akt1.

@en

P2093

Chang-Ho Ahn

http://www.w3.org/2001/XMLSchema#string

Deog Joong Kim

http://www.w3.org/2001/XMLSchema#string

Eun Hyun Ahn

http://www.w3.org/2001/XMLSchema#string

Ginelle C Gellert

http://www.w3.org/2001/XMLSchema#string

Heejeong Yoon

http://www.w3.org/2001/XMLSchema#string

Jerry W Shay

http://www.w3.org/2001/XMLSchema#string

Young Bok Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma

Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma

Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells

Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression

New colorimetric cytotoxicity assay for anticancer-drug screening

Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.

AKT plays a central role in tumorigenesis.

Antisense therapy for cancer--the time of truth.

AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells.

Antisense therapy for cancer.

P304

832-838

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.22311

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26754319

http://www.w3.org/2001/XMLSchema#string

P698

19693774

http://www.w3.org/2001/XMLSchema#string

P932

2892285

http://www.w3.org/2001/XMLSchema#string